HIV in the Era of Long-Acting Injectables: Redefining Adherence Without Abandoning Follow-Up

HIV in the Era of Long-Acting Injectables: Redefining Adherence Without Abandoning Follow-Up Reviewed and updated July 29, 2026 Abstract Purpose: This review examines how long-acting injectable antiretroviral therapy and injectable HIV pre-exposure prophylaxis are changing treatment, prevention, and adherence frameworks in HIV care. Methodology: The

HIV Treatment And Long-Acting Therapy Preferences

HIV Treatment And Long-Acting Therapy Preferences Overview Recent developments in long-acting antiretroviral therapy (LA-ART) offer promising prospects for enhancing HIV treatment by addressing adherence challenges. However, the success of these regimens depends on their acceptance among people living with HIV (PWH). To investigate patient preferences regarding LA-ART options, we conducted a discrete

HIV in the Era of Long-Acting Injectables: Redefining Adherence Without Abandoning Follow-Up